Munehiko Odaka

Title: Munehiko Odaka: Innovator in Pharmaceutical Chemistry

Introduction

Munehiko Odaka is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on trioxopteridine derivatives. With a total of 2 patents, his research focuses on developing compounds with potential medicinal applications.

Latest Patents

Odaka's latest patents include the development of trioxopteridine derivatives suitable as medicaments. These derivatives are characterized by a specific formula where R₁ is a normal alkyl group with 0 to 6 hydroxyl groups, and R₂ is either hydrogen or a normal lower alkyl group with 0 to 5 hydroxyl groups. The preparation involves catalytically hydrogenating a 6-substituted-5-nitro-2,4-dioxopyrimidine to yield a 6-substituted-5-amino-2,4-dioxopyrimidine. This compound is then reacted with another compound to produce trioxopteridine derivatives that exhibit analgesic and antiphlogistic properties, making them valuable as pharmaceutical medicaments.

Career Highlights

Munehiko Odaka is currently associated with Nippon Zoki Pharmaceutical Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic agents that can improve patient outcomes.

Collaborations

Throughout his career, Odaka has collaborated with esteemed colleagues such as Masuichi Takino and Teikichi Kurosaki. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Munehiko Odaka's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work on trioxopteridine derivatives showcases the potential for new medicinal applications that can benefit healthcare.